Recent News
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
...
Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine Use Disorder and Oral Psilocybin Thin Film Strip Program
...
Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol to FDA
...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
...